The Efficacy of Sacral Neuromodulation in the Treatment of Low Anterior Resection Syndrome: A Systematic Review and Meta-Analysis

Tech Coloproctol. 2020 Apr 30. doi: 10.1007/s10151-020-02231-8.Online ahead of print.

E Ram 1 2, R Meyer 3 4, D Carter 3 5, M Gutman 6 3, D Rosin 6 3, N Horesh 6 3


Author information

1Department of Surgery B, Sheba Medical Centre, Tel Hashomer, Israel. edward.ram@sheba.health.gov.il.

2Tel Aviv University, Tel Aviv, Israel. edward.ram@sheba.health.gov.il.

3Tel Aviv University, Tel Aviv, Israel.

4Department of Gynecology and Obstetrics, Sheba Medical Centre, Tel Hashomer, Israel.

5Department of Gastroenterology, Sheba Medical Centre, Tel Hashomer, Israel.

6Department of Surgery B, Sheba Medical Centre, Tel Hashomer, Israel.


Background: Sacral neuromodulation (SNM) has become one of the main treatment options in patients with fecal incontinence. The aim of this study was to determine the efficacy of sacral neuromodulation in the treatment of low anterior resection syndrome (LARS).

Methods: A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The search was conducted using the Pubmed, Embase, Ovid, and Cochrane databases, restricted to the English language and to articles published from 2000 to November 2018.

Results: A total of 434 articles on the efficacy of SNM in the treatment of LARS were retrieved, and 13 studies were included in the final analysis, with a total of 114 patients treated with SNM for LARS The overall success rate excluding study heterogeneity was 83.30% [95% CI (71.33-95.25%)]. Improvement in anal continence was seen in several clinical and functional parameters, including the Wexner Score [10.78 points, 95% CI (8.55-13.02), p < 0.0001], manometric maximum resting pressure [mean improvement of 6.37 mm/Hg, 95% CI (2.67-10.07), p = 0.0007], maximum squeeze pressure [mean improvement of 17.99 mm/Hg, 95% CI (17.42-18.56), p < 0.0001] and maximum tolerated volume [mean improvement of 22.74 ml, 95% CI (10.65-34.83), p = 0.0002]. Quality of life questionnaires also demonstrated significant improvement in patients' quality of life, but were reported only in a small group of included patients.

Conclusions: SNM significantly improves symptoms and quality of life in patients suffering from fecal incontinence following low anterior resection.

© Copyright 2013-2023 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.